Anticoagulation in Cirrhotic Portal Vein Thrombosis: No Harm, but Survival Benefit Still Unclear

Am J Gastroenterol. 2020 Jan;115(1):145-146. doi: 10.14309/ajg.0000000000000483.

Authors

Fabio Piscaglia¹, Francesca Benevento¹, Anna Pecorell², Antonella Forgione¹, Horia Stefanescu³

Affiliations

¹ Unit of Internal Medicine, Department of Medical and Surgical Sciences, University of Bologna, S.Orsola-Malpighi Hospital, Bologna, Italy.
² Department of Diagnostic Radiology, University of Milano-Bicocca, Milan, Italy, San Gerardo Hospital, Monza, Italy.
³ Liver Unit, Regional Institute of Gastroenterology and Hepatology "O Fodor", Cluj-Napoca, Romania.

PMID: 31809302
DOI: 10.14309/ajg.0000000000000483

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticoagulants
Humans
Liver Cirrhosis
Liver Diseases*
Portal Vein
Venous Thrombosis*

Substances

Anticoagulants